Fondaparinux vs placebo
All‐cause mortality · people with ST of the leg
Fondaparinux showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2 [0.18, 22]1 study · 3002 participantsModerate
Fondaparinux showed no clear difference in mortality compared with placebo (moderate certainty).
Fondaparinux plus vitamin K antagonist showed no clear difference in all‐cause mortality compared with standard therapy (moderate certainty).